鳞癌患者-话题@MedSci

#鳞癌患者#

19篇内容 | 380人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1822438, encodeId=e3f218224382e, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期, objectType=article, longId=725552, objectId=9947e255526a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9947e255526a, replyNumber=0, likeNumber=43, createdTime=2022-10-05, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9947e255526a, moduleTitle=BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9947e255526a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822436, encodeId=e68c182243639, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, objectType=article, longId=217545, objectId=e09321e54552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e09321e54552, replyNumber=0, likeNumber=41, createdTime=2021-10-08, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e09321e54552, moduleTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e09321e54552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822435, encodeId=62a61822435ff, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, objectType=article, longId=216219, objectId=7cde216219cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cde216219cc, replyNumber=0, likeNumber=50, createdTime=2022-04-09, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cde216219cc, moduleTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cde216219cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822437, encodeId=4f4c182243e82, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, objectType=article, longId=293004, objectId=d88b293004b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88b293004b9, replyNumber=0, likeNumber=37, createdTime=2022-11-23, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88b293004b9, moduleTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88b293004b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822434, encodeId=400b1822434ac, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, objectType=article, longId=215857, objectId=3a0b21585eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0b21585eec, replyNumber=0, likeNumber=54, createdTime=2022-03-13, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0b21585eec, moduleTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a0b21585eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822433, encodeId=6e4c182243399, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, objectType=article, longId=213435, objectId=f68521343500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68521343500, replyNumber=0, likeNumber=52, createdTime=2022-02-04, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68521343500, moduleTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68521343500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822430, encodeId=20521822430f2, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, objectType=article, longId=201080, objectId=d88e20108084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88e20108084, replyNumber=0, likeNumber=44, createdTime=2021-07-13, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88e20108084, moduleTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88e20108084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822432, encodeId=f22f1822432fd, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后, objectType=article, longId=210896, objectId=ccf4210896f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccf4210896f1, replyNumber=0, likeNumber=42, createdTime=2021-10-22, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccf4210896f1, moduleTitle=Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccf4210896f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822431, encodeId=25e4182243187, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益, objectType=article, longId=209794, objectId=fb68209e9495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb68209e9495, replyNumber=0, likeNumber=60, createdTime=2022-03-09, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb68209e9495, moduleTitle=欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb68209e9495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822428, encodeId=e27c1822428ac, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, objectType=article, longId=183912, objectId=fc8b1839120b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc8b1839120b, replyNumber=0, likeNumber=40, createdTime=2020-01-09, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc8b1839120b, moduleTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc8b1839120b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822429, encodeId=b259182242929, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术, objectType=article, longId=184375, objectId=b5451843e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5451843e5d2, replyNumber=0, likeNumber=38, createdTime=2020-10-13, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5451843e5d2, moduleTitle=病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5451843e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822427, encodeId=f7a5182242e57, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益, objectType=article, longId=154857, objectId=098c15485ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098c15485ec3, replyNumber=0, likeNumber=51, createdTime=2019-01-18, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098c15485ec3, moduleTitle=西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098c15485ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822425, encodeId=5fb31822425de, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择, objectType=article, longId=147733, objectId=907414e73367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907414e73367, replyNumber=0, likeNumber=34, createdTime=2019-08-05, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907414e73367, moduleTitle=【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907414e73367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822426, encodeId=13981822426f0, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=郭晔教授：CHANGE-2研究显示——西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益, objectType=article, longId=154502, objectId=585815450285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=585815450285, replyNumber=0, likeNumber=54, createdTime=2019-09-16, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=585815450285, moduleTitle=郭晔教授：CHANGE-2研究显示——西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=585815450285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822424, encodeId=8d3c18224246b, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=病例分享：1例ALK重排肺鳞癌患者的治疗, objectType=article, longId=144502, objectId=588d144502a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588d144502a0, replyNumber=0, likeNumber=38, createdTime=2019-05-08, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588d144502a0, moduleTitle=病例分享：1例ALK重排肺鳞癌患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=588d144502a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822422, encodeId=29b9182242285, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=JAMA Oncol：proposed-RPA分期系统可预测HPV相关口咽部鳞癌患者的生存, objectType=article, longId=80412, objectId=8d3c8041200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d3c8041200, replyNumber=0, likeNumber=41, createdTime=2017-06-08, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d3c8041200, moduleTitle=JAMA Oncol：proposed-RPA分期系统可预测HPV相关口咽部鳞癌患者的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d3c8041200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822423, encodeId=c72c1822423a9, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=BJC：食管鳞癌患者的多学科治疗策略研究, objectType=article, longId=82298, objectId=bba582298a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba582298a2, replyNumber=0, likeNumber=49, createdTime=2017-05-31, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba582298a2, moduleTitle=BJC：食管鳞癌患者的多学科治疗策略研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba582298a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822421, encodeId=f2961822421a3, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=Clin Cancer Res：他达拉非能增加头颈部鳞癌患者的肿瘤特性免疫, objectType=article, longId=46417, objectId=fe7e4641ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe7e4641ed7, replyNumber=0, likeNumber=50, createdTime=2015-05-26, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe7e4641ed7, moduleTitle=Clin Cancer Res：他达拉非能增加头颈部鳞癌患者的肿瘤特性免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe7e4641ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822420, encodeId=45ec18224205b, content=<a href='/topic/show?id=1cdd10294572' target=_blank style='color:#2F92EE;'>#鳞癌患者#</a>, objectTitle=ASCO 2014：可切除的食管鳞癌患者围术期PCF化疗方案可改善生存, objectType=article, longId=35659, objectId=013c35659a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=013c35659a7, replyNumber=0, likeNumber=49, createdTime=2015-03-24, rootId=0, userName=木头人513, userId=0045169, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=013c35659a7, moduleTitle=ASCO 2014：可切除的食管鳞癌患者围术期PCF化疗方案可改善生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=013c35659a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

鳞癌患者

2020-05-29

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期

2022-10-05

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性

2021-10-08

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！

2022-04-09

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后

2022-11-23

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！

2022-03-13

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后

2022-02-04

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后

2021-07-13

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后

2021-10-22

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益

2022-03-09

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大

2020-01-09

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术

2020-10-13

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益

2019-01-18

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择

2019-08-05

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

郭晔教授：CHANGE-2研究显示——西妥昔单抗联合化疗能使中国复发/转移性头颈部鳞癌患者获益

2019-09-16

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

病例分享：1例ALK重排肺鳞癌患者的治疗

2019-05-08

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

JAMA Oncol：proposed-RPA分期系统可预测HPV相关口咽部鳞癌患者的生存

2017-06-08

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

BJC：食管鳞癌患者的多学科治疗策略研究

2017-05-31

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

Clin Cancer Res：他达拉非能增加头颈部鳞癌患者的肿瘤特性免疫

2015-05-26

木头人513 (审核中...)

前往app查看评论内容

#鳞癌患者#

ASCO 2014：可切除的食管鳞癌患者围术期PCF化疗方案可改善生存

2015-03-24

科室
- - 订阅+
  - 更多科室
工具
服务